Company Information

1. Name

Hugel, Inc.

2. Website Address

http://www.hugel.co.kr/en/

3. Location

● HQ/ Plant 1 (Sinbuk): 61-20, Sinbuk-ro, Sinbuk-eup, Chuncheon-si, Gangwon-do 24206, Korea

● Plant 2 (Geodu): 23, Geodudanji 1-gil, Dongnae-myeon, Chuncheon-si, Gangwon-do 24398, Korea

● Seoul Office: 17F, Seongwon Tower, 514, Seolleung-ro, Gangnam-gu, Seoul 06162, Korea

4. Contacts

● HQ/ Plant 1 (Sinbuk): +82 33 255 3882

● Plant 2 (Geodu): +82 33 815 5200

● Seoul Office: +82 2 6966 1600

5. References

● Attachment 1 (50unit manual)

● Attachment 2 (100unit manual)

● Attachment 3 (200unit manual)

● Attachment 4 (150unit manual)

Pharmaceutical Product Information

1. Brand name

Botulax® 50U, Botulax® 100U, Botulax® 200U

2. Active Ingredient

Clostridium Botulinum Toxin Type A

Strain: Clostridium Botulinum CBFC26

3. Indication

1. Benign essential blepharospasm in adult patients, 18 years age or above

2. Temporary improvement of serious glabellar wrinkles ranging from moderate to severe associated with corrugators muscle and/or procerus muscle activities in adults aged between 18 and 65

4. Information

● Since 2009, “Botulax” has been marketed in 22 countries, including Korea, Japan, Thailand, Vietnam, Philippines, Chile, Peru, Uruguay, Panama, Kuwait, etc.

5. Images

Pharmaceutical Product Information

1. Brand name

Botulax® 150U

2. Active Ingredient

Clostridium Botulinum Toxin Type A

Strain: Clostridium Botulinum CBFC26

3. Indication

1. Benign essential blepharospasm in adult patients, 18 years age or above

2. Temporary improvement of serious glabellar wrinkles ranging from moderate to severe associated with corrugators muscle and/or procerus muscle activities in adults aged between 18 and 65

3. Muscle spasticity : Upper limb spasticity associated with stroke in patients aged 20 or older

4. Treatment of equinus foot deformity due to spasticity in pediatric cerebral palsy patients aged 2 years or older

4. Images